Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 Trial

TY - JOUR

T1 - Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients

T2 - The ISAR-REACT 5 Trial

AU - Mayer, Katharina

AU - Bongiovanni, Dario

AU - Karschin, Vincent

AU - Sibbing, Dirk

AU - Angiolillo, Dominick J.

AU - Schunkert, Heribert

AU - Laugwitz, Karl Ludwig

AU - Schüpke, Stefanie

AU - Kastrati, Adnan

AU - Bernlochner, Isabell

N1 - Funding Information: This work was funded by the German Center for Cardiovascular Research (DZHK) and Deutsches Herzzentrum München. Dr. Sibbing has received lecture fees from Bayer, Sanofi, AstraZeneca, Daiichi-Sankyo, Pfizer, and Roche Diagnostics; has received Advisory Board fees from Bayer, Sanofi, AstraZeneca, Daiichi-Sankyo, and Ferrer; and has received grant support from Roche Diagnostics. Dr. Angiolillo has received consulting fees or honoraria from Abbott, Amgen, Aralez, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Haemonetics, Janssen, Merck, PhaseBio, PLx Pharma, Pfizer, Sanofi, and The Medicines Company; has received payments for participation in review activities from CeloNova and St. Jude Medical; and has received institutional research grants from Abbott, Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Janssen, Matsutani Chemical Industry, Merck, Novartis, Osprey Medical, Renal Guard Solutions, and the Scott R. MacKenzie Foundation. Dr. Schunkert has received honoraria from Merck Sharp & Dohme, Amgen, Bayer Vital, Boehringer Ingelheim, Daiichi-Sankyo, Novartis, Servier, Brahms, Bristol Myers Squibb, Medtronic, Sanofi, and Synlab; and has received grant support, paid to his institution, from AstraZeneca. Dr. Schüpke has received consulting fees from Bayer Vital; and has received grant support from Else Kröner-Fresenius-Stiftung. Dr. Bernlochner has received lecture fees from Sysmex Europe GmbH. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: This work was funded by the German Center for Cardiovascular Research (DZHK) and Deutsches Herzzentrum München. Dr. Sibbing has received lecture fees from Bayer, Sanofi, AstraZeneca, Daiichi-Sankyo, Pfizer, and Roche Diagnostics; has received Advisory Board fees from Bayer, Sanofi, AstraZeneca, Daiichi-Sankyo, and Ferrer; and has received grant support from Roche Diagnostics. Dr. Angiolillo has received consulting fees or honoraria from Abbott, Amgen, Aralez, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Haemonetics, Janssen, Merck, PhaseBio, PLx Pharma, Pfizer, Sanofi, and The Medicines Company; has received payments for participation in review activities from CeloNova and St. Jude Medical; and has received institutional research grants from Abbott, Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Janssen, Matsutani Chemical Industry, Merck, Novartis, Osprey Medical, Renal Guard Solutions, and the Scott R. MacKenzie Foundation. Dr. Schunkert has received honoraria from Merck Sharp & Dohme, Amgen, Bayer Vital, Boehringer Ingelheim, Daiichi-Sankyo, Novartis, Servier, Brahms, Bristol Myers Squibb, Medtronic, Sanofi, and Synlab; and has received grant support, paid to his institution, from AstraZeneca. Dr. Schüpke has received consulting fees from Bayer Vital; and has received grant support from Else Kröner-Fresenius-Stiftung. Dr. Bernlochner has received lecture fees from Sysmex Europe GmbH. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2020/11/24

Y1 - 2020/11/24

UR - https://www.scopus.com/pages/publications/85095687671

U2 - 10.1016/j.jacc.2020.09.586

DO - 10.1016/j.jacc.2020.09.586

M3 - Letter

C2 - 33213734

AN - SCOPUS:85095687671

SN - 0735-1097

VL - 76

SP - 2569

EP - 2571

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 21

ER -